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Intravascular large cell lymphoma is a rare subtype of extranodal large cell lymphoma characterized by the presence of
neoplastic cells within the lumina of small vessels. Most cases of intravascular large cell lymphoma have a B-cell
phenotype. To date, 12 cases of intravascular natural killer (NK/)/T–cell lymphoma (IVNKL) have been reported. Our
case is A 47-year-old female presented with erythematous patches and plaques on the lower extremities mimicking
panniculitis clinically. A skin biopsy revealed intravascular lymphoma (IVL) with a NK/T cell phenotype (positive for
CD3, and granzyme B and negative for CD20, CD4, CD8, CD5). The lymphoma cells were also positive for Epstein-Barr
virus by Epstein-Barr virus-encoded RNA in situ hybridization test. Because this type of lymphoma is extremely rare,
our case is documented and compared with the previously reported cases.
Background
Intravascular lymphoma (IVL) is a rare form of
non-Hodgkin lymphoma characterized by massive
proliferation of large, neoplastic cells in small- and
medium-sized blood vessels with a predilection for the
skin and the central nervous system. This disorder
was first described as angioendotheliomatosis prolifer-
ans systemisata by Pfleger and Tappeiner [1] in 1959.
Most cases of IVL are of B-cell immunophenotype;
rare cases of NK/T-cell IVL have been reported.
To date, 12 cases of intravascular natural killer (NK)/
T–cell lymphoma (IVNTKL) have been reported, our
case is the 13th. Because this variant is extremely rare,
our case is documented and compared with the previ-
ously reported cases
Case presentation
A 48-year-old woman visited a dermatology clinic
complaining erythematous patches and nodules on her
lower extremities noted for 3 months. The lesions
were not painful or pruritic. The results of all labora-
tory studies, including CBC count, liver function tests
were unremarkable. Her medical and family histories
were unremarkable. Under the impression of pannicu-
litis, a skin biopsy was taken from a lesion on her leg.
The histological study revealed many distended vessels
filled with atypical large lymphoid cells in the subcuta-
neous tissue (Fig. 1). The tumor cells were all confined
to the vessels and had large, irregular hyperchromatic
nuclei with an ample eosinophilic cytoplasm (Fig. 2).
Many mitotic figures and necrosis were observed.
Immunohistochemical studies showed that tumor cells
were CD45+ CD3+ (Fig. 3-a), Granzyme B+ (Fig. 3-b),
CD56−, CD4−, CD5−, CD8−, CD20− (Fig. 3c), CD30−. In
situ hybridization for EBER was positive (Fig. 4). The
immunophenotype suggested that the intravasacular
cells were NK/T-cell–like lymphoid cells. Bone mar-
row biopsy and aspirate revealed no evidence of tumor
involvement. The patient did not have nasal lymph-
oma. The absence of peripheral leukemia and the lack
of bone marrow involvement excluded the possibility
of an aggressive NK-cell leukemia. The immunohisto-
chemical tests and EBER in situ hybridization as well
as the clinical finding suggested IVNKTL. After this
diagnosis, Computed tomography scan and magnetic
resonance imaging (MRI) of the brain, chest and abdo-
men were done and were unremarkable. Following
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combination chemotherapy the patient was alive with
no evidence of disease at 18 months.
Conclusions
IVL is a very rare neoplasm characterized by prolifera-
tion of lymphoma cells almost exclusively within
the blood vessels. Originally described in 1959 as
“angioendotheliomatosis proliferans systemisata” and
considered an endothelial neoplasm, IVL has subse-
quently been shown to be a lymphoid malignancy
based on immunohistochemical techniques [1–3]. The
majority of reported cases were large B-cell lymph-
omas, only a few cases were reported to be of the T
and NK-cell lineage. Since 2003, 12 cases of IVNKL
have been reported worldwide. The current case is
the 13th.
Recognized variants of NK cell lymphomas include a
clinicopathologic spectrum of predominantly extrano-
dal disease, including nasal and extranasal types, and
aggressive NK cell leukemia/lymphoma [3, 4]. IVNKL
should be distinguished from the extranodal NK/T-cell
lymphoma, nasal type (ENKTCL). Although ENKTCL
can also occur in the skin but presents with multiple
nodules with ulceration and the tumor cells are
distributed in tissues and show vascular invasion.
Patients with IVNKTL have no nasal abnormalities
and tumor cells are confined to the endovascular sys-
tem. IVNKTL should also be distinguished from ag-
gressive NK-cell leukemia. A rash is typically
prominent in IVNKTL without obvious abnormalities
in the peripheral blood, although bone marrow abnor-
malities might be present in some patients. In aggres-
sive NK-cell leukemia, tumor cells are diffusely
scattered in the extravascular tissue rather than depos-
ited in blood vessels.
Why are all tumor cells distributed intravascularly in
IVNKTL? The lack of adhesion molecule (CD29 and
CD54) expression by tumor cells in intravascular large
B-cell lymphoma is thought to explain why these
tumor cells do not infiltrate extravascular sites [4].
Whether similar mechanisms exist in IVNKTL is not
yet known. The high prevalence of EBER positivity in
IVNKTL suggests that EBV infection is somehow
involved in the pathogenesis of this rare lymphoma.
Because these are rare cases, the origin of intravascu-
lar NK/T-cell lymphoma has not been studied in
depth. Only two of the 12 cases had T-cell receptor
gene rearrangement analysis performed, which confirmed
NK/T-cell origin [5].
The age range of the reported IVNKL cases was be-
tween 4–71 years. The clinical course lasted from
2 months to 3 years. Multisystem involvement (brain,
bone marrow, spleen, and kidney) occurred in eight of
13 patients (61.5 %). The other five patients including
our case developed only a skin rash. Among the 13
cases, four (30.7 %) were reported in China, two
(15.3 %) in Taiwan, two (15.3 %) in the United States,
one (7.6 %) in Austria, one 7.6 %) in Japan, one in
Korea, one (7.6 %) in Italy and one in Saudi Arabia
(7.6 %). Nine (69.2 %) of 13 of the reported cases were
Fig. 1 Scanning view of the cutaneous lesion revealing
subcutaneous abnormal obstructed vessels (H/E, ×20)
Fig. 2 Higher magnification showing distended vessels containing
atypical lymphoid cells with focal fibrin thrombi (H/E, ×400)
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encountered in Asian countries. Nine out of 13 pa-
tients were female (69.2 %) and four were male
(30.8 %) [4–15].
The prognosis for IVL in general might vary depend-
ing on the extent of disease. Patients with limited
disease such as skin lesions, as noted in our case, or
single organ involvement might respond well to
chemotherapy. Patients with disseminated disease,
particularly those with CNS involvement, have done
poorly [4–15].
In conclusion, Although the majority of IVL cases
are B cell in lineage, rare cases of T or NK-cell lymph-
oma can occur as IVL. Because this variant is ex-
tremely rare, our case is documented and pathologists
should be aware that NK-cell lymphoma can also
occur intravascularly as cutaneous lymphoma with or
without affecting other internal organs. The diagnosis
can be established by combined histopathologic, im-
munohistochemical, and molecular studies. The role
of EBV in the oncogenesis of IVNKL requires further
investigation. More cases should be documented for
further understanding of this peculiar rare type of
lymphoma.
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